Dustin Allison, Interim Chief Executive Officer | Greater St. Louis Chamber
Dustin Allison, Interim Chief Executive Officer | Greater St. Louis Chamber
St. Louis-based C2N Diagnostics is expanding its operations, tripling its size and relocating its headquarters to Catalyst, Powered by WashU, in the Cortex Innovation District. The move comes as the company seeks to address growing global demand for solutions to Alzheimer’s Disease.
Dustin Allison, Interim CEO of Greater St. Louis, Inc., commented on the development: "C2N’s expansion in St. Louis is yet another example of our region’s strength in neuroscience research. C2N’s investment here is not only deeply important to human health, but also to our region’s economic development. C2N's announcement is clear evidence that growth and innovation are valued in this region, and that our community will work in intentional, collaborative ways with business partners looking for a welcoming place to grow their enterprise."
Earlier this year, legislation passed by the St. Louis Board of Aldermen supported Washington University’s $100 million redevelopment of the former Goodwill Building. This support was instrumental in keeping C2N Diagnostics headquartered in St. Louis and enabling it to expand as the building's anchor tenant.
Dr. David Holtzman, Co-Founder of C2N Diagnostics, said: “I am so pleased that C2N Diagnostics chose to remain in the city where it was founded, and that it will be housed in a building renovated and backed by WashU. The company’s future is bright, and the new headquarters at Catalyst will support growth, collaboration and advancement as its researchers seek new tools to better diagnose, prevent and treat Alzheimer’s disease and other neurodegenerative conditions.”
Greater St. Louis, Inc., along with local and state partners such as Missouri Governor Mike Kehoe; Mayor Cara Spencer; Alderman Michael Browning; Cortex Innovation District; Cushman & Wakefield; Missouri Department of Economic Development; St. Louis Development Corporation; and Washington University in St. Louis played roles supporting C2N during its expansion process.
According to information from C2N Diagnostics, dynamic growth has led the company to expand its headquarters as it works toward addressing Alzheimer's disease globally.
The Missouri Department of Economic Development reported that C2N's expansion involves millions of dollars invested locally along with plans for significant hiring.
Washington University has outlined plans for redeveloping the Goodwill complex into a modern facility aimed at fostering research collaborations (WashU).
Alerts Sign-up